Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04068493 · ClinicalTrials.gov registry record · NA

A Dissonance-Based Obesity Intervention

A NA study, sponsored by University of Illinois at Chicago.

Terminated
Registry status
NA
Development phase
7
Enrollment target

NCT04068493: Clinical Trial NA study, sponsored by University of Illinois at Chicago.

NCT04068493 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04068493, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.

TERMINATED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

This project will examine the feasibility and acceptability of Enhanced Project Health, a dissonance-based obesity intervention, and whether this intervention results in significantly greater reductions in weight and improvements in lifestyle behaviors than an assessment only condition. Participants will be young adults enrolled in college.

Primary Outcome

This will be defined as a percentage of young adults that agree to participate in study out of the young adults screened for the study.

Interventions

  • BEHAVIORAL Enhanced Project Health

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2021-09-01
Est. Completion 2022-02-18
Phase NA
University of Illinois at Chicago

430 total trials

Why NCT04068493 stopped before completion

NCT04068493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Enhanced Project Health is the first listed.

NCT04068493 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04068493 about?

NCT04068493 is a clinical study titled "A Dissonance-Based Obesity Intervention". This project will examine the feasibility and acceptability of Enhanced Project Health, a dissonance-based obesity intervention, and whether this intervention results in significantly greater reductions in weight and improvements in lifestyle behaviors than an assessment only condition. Participants...

What is the current status of trial NCT04068493?

This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2021-09-01. Estimated completion is 2022-02-18.

What interventions are being tested in trial NCT04068493?

The interventions under investigation include: Enhanced Project Health (BEHAVIORAL).

Who is sponsoring clinical trial NCT04068493?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04068493's enrollment target sits among peer trials

7 1982nd of 2000 higher than 18 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04068493, the US trial registry maintained by the National Library of Medicine. NCT04068493 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.